Peptide Therapy
Tirzepatide – Dual Action Weight Loss
Usage Note: Tirzepatide is an excellent option to follow after starting with Semaglutide, as it tends to cause less nausea while providing similar weight loss benefits. We recommend taking a 4-6 week break every 4 months to avoid dose increases.
Build Your Ideal Treatment Plan
Dual Action for Enhanced Weight Loss
Tirzepatide combines the benefits of Semaglutide with the added action of GIP, providing a more comprehensive weight loss solution. This dual-acting therapy reduces appetite, controls blood sugar, and provides significant weight loss with less nausea compared to Semaglutide.
- Maximizes weight loss: Combines the effects of GLP-1 and GIP for optimal fat reduction.
- Reduces appetite: Keeps you feeling satisfied, making it easier to resist cravings.
- Typically less nausea than Semaglutide: Easier to tolerate, with fewer side effects.
- Decreases overall calorie intake: Helps naturally reduce food consumption without effort.
- Improves metabolic function: Helps manage blood sugar and supports better glucose control.
- Regulates insulin production: Improves insulin sensitivity, essential for metabolic health.
- Combines GLP-1 and GIP action: Provides dual benefits for more efficient weight loss.
- Curbs food cravings: Helps prevent overeating and emotional eating.
Tirzepatide is the ideal choice for those looking to enhance their weight loss results with a modern, dual-action approach.